跳至主要内容
临床试验/NCT02844959
NCT02844959Unknown不适用

Assessment of Course of Inflammatory Biomarkers Concentrations After Pulmonary Veins Isolation as a Prognostic Factor of Atrial Fibrillation Treatment Effectiveness (ACtIVE-AF Study)

Medical University of Warsaw1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2016年7月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
Atrial fibrillation within the first 7 days after ablation

研究概览

简要总结

The aim of this study is to evaluate inflammatory response as a prognostic factor of atrial fibrillation recurrency after ablation. Inflammatory response will be assessed by double measurement of C-reactive protein, fibroblast growth factor 2 (FGF2), matrix metallopeptidase 8 (MMP8) and body temperature. Dynamics of change of troponin I will be measured additionally.

After ablation each patient will be monitored with ECG telemonitoring system for 7 days.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • signed consent;
  • criteria for ablation of atrial fibrillation.

排除标准

  • previous pulmonary veins isolation;
  • ablation other than pulmonary veins isolation during the procedure;
  • atrial fibrillation at the beginning of ablation procedure;
  • usage of 'single shot' devices.

结局指标

主要结局

Atrial fibrillation within the first 7 days after ablation

时间窗: within the first 7 days after ablation

次要结局

  • Atrial fibrillation within 6 months after ablation(6 months)

研究者

发起方
Medical University of Warsaw
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marcin Grabowski

Clinical Professor, Marcin Grabowski, Medical University of Warsaw

Medical University of Warsaw

研究点 (1)

Loading locations...

相似试验